LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
To help evaluate a person's immune system status; to detect and monitor an excess or deficiency in one or more of the immunoglobulin classes (IgG, IgA, and IgM)
When you have recurrent infections and/or chronic diarrhea; when your healthcare practitioner suspects an immunoglobulin deficiency or excess of a particular immunoglobulin; periodically to monitor a condition that affects immunoglobulin levels that may be genetic (selective IgA deficiency) or acquired (HIV/AIDS, multiple myeloma)
A blood sample is obtained by inserting a needle into a vein in the arm. When required, a sample of cerebrospinal fluid (CSF) is collected by a healthcare practitioner from the lower back using a procedure called a lumbar puncture or spinal tap. Saliva or other fluids are collected in a container provided by the laboratory.
Immunoglobulins play a key role in the body's immune system. They are proteins produced by specific immune cells called plasma cells in response to bacteria, viruses, and other microorganisms as well as exposures to other substances that are recognized by the body as "non-self" harmful antigens. This test measures the amount of immunoglobulins A, G, and M (IgA, IgG, IgM) in the blood and, in certain circumstances, in cerebrospinal fluid (CSF) or saliva.
The first time a person is infected or otherwise exposed to a foreign substance (antigen), their immune system recognizes the microorganism or substance as "non-self" and stimulates plasma cells to produce specific immunoglobulin(s), also called antibodies, that can bind to and neutralize the threat. With subsequent exposures, the immune system "remembers" the antigen that was encountered, which allows for the rapid production of more antibodies and, in the case of microorganisms, helps prevent re-infection.
There are five classes of immunoglobulins and several subclasses. Each class represents a group of antibodies and has a slightly different role. Classes of immunoglobulins include:
Immunoglobulins testing measures the total amount of each primary immunoglobulin class, IgA, IgM, and IgG, without distinguishing between subclasses. Separate testing can be performed to measure immunoglobulin subclasses and/or to detect and measure specific antibodies.
A variety of conditions can cause an increase (hypergammaglobulinemia) or decrease (hypogammaglobulinemia) in the production of immunoglobulins. Some cause an excess or deficiency of all classes of immunoglobulins while others affect only one class. Some of the conditions are passed from one generation to the next (inherited) and others are acquired.
A test for immunoglobulins (Igs) is used to detect an excess or deficiency in the three major classes of immunoglobulins (IgG, IgA, and IgM). It gives important information about the health of an individual's immune system and is used to help diagnose various conditions and diseases that affect the levels of one or more of these Ig classes.
In general, immunoglobulin disorders can be classified as:
This test may be ordered along with others, such as a serum and/or urine protein electrophoresis, to help diagnose and monitor conditions associated with abnormal or excessive immunoglobulin production. When this is the case, a urine sample may be collected in addition to blood.
If an excessive amount of one of the immunoglobulin types is present, further testing by immunofixation can be done to determine if the immunoglobulin comes from clones of an abnormal plasma cell (monoclonal gammopathy). Monoclonal gammopathies are seen with multiple myeloma, a malignancy of plasma cells. Serum free light chain testing may also be performed.
This test is ordered when a person has symptoms of an immunoglobulin deficiency such as recurrent infections, especially of the respiratory tract (sinus, lungs) or digestive system (stomach, intestines), and/or chronic diarrhea.
Immunoglobulins testing may also be ordered when a person has signs of chronic inflammation or chronic infection and when a healthcare practitioner suspects excess or abnormal immunoglobulin production. The test may be ordered periodically to monitor the course of a person's condition.
This test may also be performed on cerebrospinal fluid (CSF) whenever a healthcare practitioner suspects that a condition affecting the central nervous system may be associated with excess immunoglobulin production.
The results of the tests for IgG, IgA, and IgM levels are usually evaluated together. Abnormal test results typically indicate that there is something affecting the immune system and suggest the need for further testing. Immunoglobulins testing is not diagnostic but can be a strong indicator of a disease or condition. There are a number of conditions that are associated with increased and decreased immunoglobulins.
Increased polyclonal immunoglobulins may be seen with a variety of conditions.
Monoclonal immunoglobulins are seen in blood cell tumors that involve lymphocytes or plasma cells. In these disorders, there is typically a marked increase in one class of immunoglobulin and a decrease in the other two classes. Although affected people may have an increase in total immunoglobulins, they are actually immunocompromised because most of the immunoglobulins produced are abnormal and do not contribute to the immune response.
The following table lists some examples of conditions that may cause increased immunoglobulins:
|Immunoglobulin Result||Associated Conditions|
|Polyclonal increase in any or all of the three classes (IgG, IgA and/or IgM)||
|Monoclonal increase in one class with or without decrease in other two classes||
The most common causes of decreased immunoglobulins are acquired underlying (secondary) conditions that either affect the body's ability to produce immunoglobulins or that increase the loss of protein from the body. Deficiencies may also be due to drugs such as immunosuppressants, corticosteroids, phenytoin, and carbamazepine or due to toxins.
The table below lists some of the common causes of low levels:
|Conditions/factors that affect immunoglobulin production|
|Conditions that cause an abnormal loss of protein||
Inherited immune deficiencies are rare and are often referred to as primary immunodeficiencies. They may affect the production of all immunoglobulins, a single class, or one or more subclasses. Some of these disorders include agammaglobulinemia, common variable immunodeficiency (CVID), x-linked agammaglobulinemia, ataxia telangiectasia, Wiskott-Aldrich syndrome, hyper-IgM syndrome, and severe combined immunodeficiency (SCID).
In CSF, immunoglobulins normally are present in very low concentrations. Increases may be seen, for example, with central nervous system infections (meningitis, encephalitis), inflammatory conditions, and multiple sclerosis.
Decreases in salivary IgA may be seen in those with recurrent respiratory infections.
People with conditions that cause decreased immunoglobulin levels often do not have a strong immune response to vaccinations; they may not produce a sufficient level of antibody to ensure protection and may not be able to receive live vaccines, such as those for polio or measles.
Many laboratory tests measure antibodies in the blood. Those with immunoglobulin deficiencies may have false-negative results on these types of tests. For example, one test for celiac disease detects the IgA class of anti-tissue transglutaminase antibody (anti-tTG). If a person has a deficiency in IgA, then results of this test may be negative when the person, in fact, has celiac disease. If this is suspected to be the case, then a quantitative test for IgA may be performed.
If IgG or IgA concentrations are decreased, or a deficiency in one of their subclasses is suspected, then subclass testing may be performed to detect and further define the deficiency. Subclass deficiencies can be present even when an immunoglobulin class concentration, such as IgG, is normal.
Some people with IgA deficiencies may develop anti-IgA antibodies. When those with anti-IgA are given blood component transfusions that contain IgA (such as plasma or immunoglobulin treatments), they may experience a severe anaphylactic transfusion reaction.
Sometimes an IgM test is used to determine whether a newborn acquired an infection before birth (congenital). IgM may be produced by a developing baby (fetus) in response to infection. Due to the size of IgM antibodies, they cannot pass through the placenta from mother to baby during pregnancy. Thus, any IgM antibodies present in a newborn's blood are not from the mother but were produced by the baby. This indicates that an infection began during pregnancy.
Infants with otherwise normal immune systems may have temporarily decreased IgG levels when production is delayed. Protection from infections is lost as concentrations of the mother's IgG in the baby's blood decrease over several months. The level of IgG remains at low concentrations until the baby's IgM and IgG production ramps up. This creates a period of time during which the baby is at an increased risk for recurrent infections.
However, infants who are breastfed acquire IgA from breast milk. The IgA in breast milk can be protective against infections, particularly in the time between the decrease of mother's antibodies and the production of the baby's own antibodies.
In most cases, immunoglobulins do not respond to lifestyle changes. If you are taking a drug that is decreasing one or more of your immunoglobulins, then you and your healthcare practitioner may decide to alter your medications. It is very important, however, NOT to discontinue or change your medication dosage without consulting with your healthcare provider.
Infants gradually lose protection from infections as the levels of IgG they receive through the placenta from their mothers decrease after birth. Greater protection can be provided for babies through breastfeeding since breast milk contains IgA, which protects against infections.
Not specific ones. Unexplained recurrent infections, multiple infections, or opportunistic infections, with or without chronic diarrhea, may indicate a need to check a person's immune status. A positive family history of an immunodeficiency may also require follow up. A thorough physical examination and a careful medical history can be critical to a diagnosis.
You may have been directed to give a urine sample to check for the presence of protein in your urine and/or to determine the amount and type of protein present in your urine. Your healthcare practitioner may suspect that, based on your medical history, signs and symptoms and/or other test results, you have a condition associated with abnormal or excessive immunoglobulin production. In such cases, a quantitative immunoglobulin test is often performed along with tests such as serum and urine protein electrophoresis to help establish a diagnosis.
Sources Used in Current Review
2018 review performed by Mary M. Mayo, PhD, DABCC, FAACC, Global Medical and Scientific Affairs, Beckman Coulter.
©2018 Immune Deficiency Foundation. Specific Disease Types. Available online at https://primaryimmune.org/about-primary-immunodeficiencies/specific-disease-types/. Accessed on 7/11/2018.
(October 29, 2015) International Myeloma Working Group (IMWG) Criteria for the Diagnosis of Multiple Myeloma. Available online at http://imwg.myeloma.org/international-myeloma-working-group-imwg-criteria-for-the-diagnosis-of-multiple-myeloma/. Accessed on 7/11/2018.
Stevens, Christine D and Miller, Linda E (copyright 2017). Clinical Immunology and Serology: A Laboratory Perspective, 4th Edition: F.A Davis Company, Philadelphia, PA. pp 65-69 and 326-343.
Sources Used in Previous Reviews
(© 2009). Mayer, G. Immunology – Chapter Four, Immunoglobulins – Structure and Function. Microbiology and Immunology On-line, University of South Carolina School of Medicine [On-line information]. Available online at http://pathmicro.med.sc.edu/mayer/IgStruct2000.htm. Accessed June 2010.
Blood Test: Immunoglobulins (IgA, IgG, IgM). KidsHealth from Nemours [On-line information]. Available online at http://kidshealth.org/parent/system/medical/test_immunoglobulins.html. Accessed June 2010.
Dugdale, D. (Updated 2008 June 14). Quantitative immunoglobulins – nephelometry. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003545.htm. Accessed June 2010.
Delgado, J. et. al. (Updated 2010 January). Immunoglobulin Disorders. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/ImmunoglobulinDisorders.html. Accessed June 2010.
Lin, R. et. al. (Updated 2009 August 26). Hypogammaglobulinemia eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/136471-overview. Accessed June 2010.
Bascom, R. and Dolina, M. (Updated 2009 September 29). Immunoglobulin A Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/136580-overview. Accessed June 2010.
Hussain, I. et. al. (Updated 2009 July 21). Immunoglobulin M Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/137693-overview. Accessed June 2010.
Lin, R. and Schwartz, R. (Updated 2009 July 9). Immunoglobulin G Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/136897-overview. Accessed June 2010.
Dibbern Jr, D. and Routes, J. (Updated 2009 December 2). Immunoglobulin D Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/136803-overview. Accessed June 2010.
Pagana, K. D. & Pagana, T. J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 564-566.
Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 598-611.
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds (2005). Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 1921-1922, 1940-1945.
Sanford KW, Roseff SD. Immunodeficiency Disorders. Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed. RA McPherson and MR Pincus, eds. Saunders:New York, Pp 906-915, 2007.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006 Pp 571-573, 578, 580.
Vadde, R. and Schmidt, M. (Updated 2013 July 1). Immunoglobulins. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/2157901-overview. Accessed March 2014.
Delgado, J. et. al. (Updated 2013 November) Immunoglobulin Disorders. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/ImmunoglobulinDisorders.html. Accessed March 2014.
(© 1995–2014). Immunoglobulins (IgG, IgA, and IgM), Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/8156. Accessed March 2014.
Durani, Y. (Reviewed 2012 October). Immune System. KidsHealth from Nemours [On-line information]. Available online at http://kidshealth.org/parent/general/body_basics/immune.html. Accessed March 2014.
Dugdale, D. (Updated 2012 June 5). Quantitative nephelometry. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003545.htm. Accessed March 2014.
(Revised 2013 June 19). Waldenstrom Macroglobulinemia. American Cancer Society [On-line information]. Available online at http://www.cancer.org/acs/groups/cid/documents/webcontent/003148-pdf.pdf. Accessed March 2014.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby's Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 581-584.
Clarke, W., Editor (© 2011). Contemporary Practice in Clinical Chemistry 2nd Edition: AACC Press, Washington, DC. Pp 237-239.
McPherson, R. and Pincus, M. (© 2011). Henry's Clinical Diagnosis and Management by Laboratory Methods 22nd Edition: Elsevier Saunders, Philadelphia, PA. Pp 846-847.
Wintrobe's Clinical Hematology. 12th ed. Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means R, eds. Philadelphia, PA: Lippincott Williams & Wilkins: 2009, Pp 2342-2343.